Development of the AGREE II, part 1: performance, usefulness and areas for improvement. - Wikidata - wikimedia - TriplyDB

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

http://www.wikidata.org/entity/Q33976005

about

Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders Acute hypertension: a systematic review and appraisal of guidelines A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with Appraisal of Guidelines for Research and Evaluation II Guide to clinical practice guidelines: the current state of play Collaborative Research in Childhood Cancer Survivorship: The Current Landscape 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Evaluation of the acceptability, feasibility and effectiveness of two methods of involving patients with disability in developing clinical guidelines: study protocol of a randomized pragmatic pilot trial.Tools for assessing the content of guidelines are needed to enable their effective use--a systematic comparison Recruitment of multiple stakeholders to health services research: lessons from the front lines.A randomized trial to evaluate e-learning interventions designed to improve learner's performance, satisfaction, and self-efficacy with the AGREE II.Development of the AGREE II, part 2: assessment of validity of items and tools to support application.Quality and consistency of guidelines for the management of mild traumatic brain injury in the emergency department.Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals.An evaluation of web-based clinical practice guidelines for managing problems associated with cannabis use.AGREE II: advancing guideline development, reporting and evaluation in health care.Tools to support evidence-informed public health decision making.A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue.Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument.Addressing implementation challenges during guideline development - a case study of Swedish national guidelines for methods of preventing disease From Concept to Bedside: What Pediatricians Should Know about Synthesis of Clinical Practice Guidelines?E-learning interventions are comparable to user's manual in a randomized trial of training strategies for the AGREE II.The Guideline Implementability Decision Excellence Model (GUIDE-M): a mixed methods approach to create an international resource to advance the practice guideline field.The quality of web-based oncology guidelines and protocols: how do international sites stack up?Effective interventions to facilitate the uptake of breast, cervical and colorectal cancer screening: an implementation guideline.Process description and evaluation of Canadian Physical Activity Guidelines development.Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.Clinical practice guidelines within the Southern African Development Community: a descriptive study of the quality of guideline development and concordance with best evidence for five priority diseases Prospective systematic review registration: perspective from the Guidelines International Network (G-I-N)Validation and reliability of a guideline appraisal mini-checklist for daily practice use.Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.Appraisal of clinical practice guidelines for management of paediatric type 2 diabetes mellitus using the AGREE II instrument: a systematic review protocol.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.An international study of the quality of national-level guidelines on driving with medical illness.Reliability of Quality Assessments in Research Synthesis: Securing the Highest Quality Bioinformation for HIT Methodological Quality of Consensus Guidelines in Implant Dentistry.Formulation of evidence-based messages to promote the use of physical activity to prevent and manage Alzheimer's disease Quality of clinical practice guidelines in delirium: a systematic appraisal.Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.Health system guidance appraisal--concept evaluation and usability testing

P2860

Q26771677-DC113FE4-224D-4004-834C-C5E4D05C48EA Q27011845-9DA071AC-3DB2-4A20-910D-DF32C5B4F07D Q27021435-4028F351-61B0-41DE-A2C8-4EDD25E7F74F Q28073203-49DE825C-9DE4-4BC7-A022-9DC5C9EF8457 Q28081135-965C823E-F807-4D64-8BEF-A06935DB4684 Q28392783-46F97458-2439-4B1A-A2F2-F522E86D2EA3 Q28394414-EB2F8395-B035-4B16-9D3E-8389E1E222B1 Q30578209-A2E72FA2-0408-4F6E-A100-98E58ABE8621 Q30605821-081DE617-C67E-407C-B5FB-B86754043EAB Q33577367-88C45889-2E4B-4FCE-A81E-AAFAB48D9573 Q33843445-6CC83FA0-A074-4ABD-8C2A-A8A89E885FE3 Q33976144-D62546A5-0BB0-42D4-B485-3EFD5FB8FE2B Q33993354-E02209D5-CC2D-4518-9063-3CAA9E26D605 Q34266960-B98553F3-8812-4D53-BA09-2E3FE0F43F36 Q34318337-D7302E86-5D90-498A-96FB-DF05311B1684 Q34403979-36508E6B-2394-4D89-89E0-62FD2431EA9D Q34468686-4DD6E907-465B-4A96-971F-74C06CDFA35D Q34758100-6ADC9964-2411-4209-95AA-1F75A5161044 Q34909789-31CE7B83-3D60-4477-A913-B14D24CF3EF3 Q35018977-EA98F345-2C00-44FB-8461-81D8C809CF36 Q35176675-5AC74880-63BA-4F8D-BD23-5373BBFDC4BA Q35183355-C7EF488F-9861-4184-8965-F2455EA038A3 Q35191072-50C1E3F7-C59C-4534-A236-C929CB8521BB Q35527152-B5FA7E32-79D7-4AFE-9751-4BD051B78EC5 Q35568745-DC01A4FA-5778-4F22-890C-AA7DF5DC7BC5 Q35575293-57F78C72-6AA4-42D3-B436-41D782DC5218 Q35762508-2BF8A92C-9BF8-4F31-9876-49313301DF0F Q35777097-FF62D516-3298-4E7E-BD28-6FF342AC4A87 Q35948008-8D7D09F2-5BC3-4C06-A91C-109AC3F7526F Q35978094-BD64401D-919A-4ADD-84FC-20E0CBF4D15C Q36027085-6E7B74E7-4A62-42B1-80B3-BE1CEEAC8307 Q36076695-8B301165-9714-446B-ABB5-93C87914A698 Q36153966-089CC2CC-1438-460F-88BA-896CBA50E143 Q36206735-0ED3776E-C024-42D9-86D8-CF923478C809 Q36254395-2A251D12-52AD-431F-AC16-11D746E0867B Q36255534-8B798442-083F-43BF-88AC-743E2E32F2EB Q36284477-C33068E4-BC8E-4407-8B9E-1CC262451A2B Q36304882-CE55A64E-654D-4718-BD0E-7C3ED8895776 Q36398661-93ABAC30-77ED-4F85-9149-670432610C3A Q36428434-1DEF154D-B0EC-45B5-8BBD-4C83FB62FF62

P2860

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

http://www.wikidata.org/entity/Q33976005

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@ast

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@en

type

label

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@ast

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@en

prefLabel

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@ast

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@en

P1433

Q33976005-FD1797F2-94EE-46EB-8553-6CDD603B4CE6

P1476

Q33976005-0CB9CCF3-799A-43CE-8EDA-1456D796AA7B

P2093

Q33976005-1AEFA683-6F5C-4E4A-9517-996CA078B72C

Q33976005-41921099-536B-485A-AED7-8CF7938C0FCC

Q33976005-6413106D-76FA-41E8-BADA-3FF58C63AACC

Q33976005-645B9005-E647-4288-867D-EF9427C42F37

Q33976005-AB051EAE-C898-4F71-8C26-F4831CA8EE1C

Q33976005-B50C8998-4EC9-4D1C-A2EC-EF269D04CA60

Q33976005-C8E7EE69-E4AC-469F-A896-858CB49B116B

Q33976005-F7200F1E-5635-4FCC-8AB3-5B793667A87E

P2860

Q33976005-22FE3D4B-136E-479B-B615-45CD8C03E2B6

Q33976005-42A4DCE1-4FDE-42E4-B033-6B22C2167649

Q33976005-56BD02D1-1ECD-4354-A12D-6C31DC2B72F0

Q33976005-5F90A1FD-C3B8-44CF-829B-44B2CD1EA12E

Q33976005-6C914483-A3BA-4C58-99D5-3D91AC4EC139

Q33976005-6E79727A-58A9-4538-909A-C36936EC616C

Q33976005-8ADC9AE9-DBAA-407D-8DC0-D90C46C20FBD

Q33976005-A5847FA5-E670-40B8-BBC9-851CF2DA1F99

Q33976005-A6652EFB-1C48-4DB1-8B3B-E04F5E2E1853

Q33976005-B37BAAD7-67F0-49EE-B715-7876B006670B

P304

Q33976005-2598DAB5-91AA-43B3-AA0C-8D7638E87803

P31

Q33976005-FCE41AFB-07A9-4E5A-9BF3-2730FB3BFA9F

P356

Q33976005-8104C3C1-7095-4CB8-85A8-0B13E6A030DB

P407

Q33976005-1D28CF05-58CC-4D7E-AAAF-9E28D51294FE

P433

Q33976005-B4347D6F-75A7-4CFD-88C0-AD60668008B8

P478

Q33976005-812F4279-FD97-4030-85CD-935F420AAFA6

P50

Q33976005-0E480BF7-E7FA-4BD5-BDAA-166EBA860D28

Q33976005-440A16B7-762C-435E-87C6-03D6D462001D

Q33976005-E0A1225B-3A68-4584-AA29-2B8A1229C829

Q33976005-E312DE02-A7A9-480D-A5E6-B8CDA6CA02CA

P577

Q33976005-A09C44A2-0932-451A-8DDB-CC26073D7EC5

P5875

Q33976005-137DC693-AC28-4C24-A07A-978B41EE97BB

P698

Q33976005-AE850A75-E8FA-48F7-80F5-CC98CDED96E0

P932

Q33976005-0A02799F-3B78-468F-9FCF-082CBA0951BF

P356

P1433

Canadian Medical Association Journal

P1476

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

@en

P2093

AGREE Next Steps Consortium

http://www.w3.org/2001/XMLSchema#string

Béatrice Fervers

http://www.w3.org/2001/XMLSchema#string

Francoise Cluzeau

http://www.w3.org/2001/XMLSchema#string

George P Browman

http://www.w3.org/2001/XMLSchema#string

Jako S Burgers

http://www.w3.org/2001/XMLSchema#string

Julie Makarski

http://www.w3.org/2001/XMLSchema#string

Melissa C Brouwers

http://www.w3.org/2001/XMLSchema#string

Steven E Hanna

http://www.w3.org/2001/XMLSchema#string

P2860

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

Recruitment of multiple stakeholders to health services research: lessons from the front lines.

Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature.

Development of the AGREE II, part 2: assessment of validity of items and tools to support application.

AGREE II: advancing guideline development, reporting and evaluation in health care.

Clinicians' assessments of practice guidelines in oncology: the CAPGO survey.

A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit.

Quality of systematic reviews used in guidelines for oncology practice.

P304

1045-1052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.091714

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Béatrice Fervers

Michelle E. Kho

P577

2010-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44640885

http://www.w3.org/2001/XMLSchema#string

P698

20513780

http://www.w3.org/2001/XMLSchema#string

P932

2900328

http://www.w3.org/2001/XMLSchema#string